Literature DB >> 20348497

TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria.

Nadia A Sam-Agudu1, Jennifer A Greene, Robert O Opoka, James W Kazura, Michael J Boivin, Peter A Zimmerman, Melissa A Riedesel, Tracy L Bergemann, Lisa A Schimmenti, Chandy C John.   

Abstract

Toll-like receptor (TLR) polymorphisms have been associated with disease severity in malaria infection, but mechanisms for this association have not been characterized. The TLR2, 4, and 9 single nucleotide polymorphism (SNP) frequencies and serum interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) levels were assessed in Ugandan children with cerebral malaria (CM, N = 65) and uncomplicated malaria (UM, N = 52). The TLR9 C allele at -1237 and G allele at 1174 were strongly linked, and among children with CM, those with the C allele at -1237 or the G allele at 1174 had higher levels of IFN-gamma than those without these alleles (P = 0.03 and 0.008, respectively). The TLR9 SNPs were not associated with altered IFN-gamma levels in children with UM or altered TNF-alpha levels in either group. We present the first human data that TLR SNPs are associated with altered cytokine production in parasitic infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348497      PMCID: PMC2844552          DOI: 10.4269/ajtmh.2010.09-0467

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  51 in total

1.  A comparison of linkage disequilibrium measures for fine-scale mapping.

Authors:  B Devlin; N Risch
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

2.  Interferon-gamma is essential for the development of cerebral malaria.

Authors:  W Rudin; N Favre; G Bordmann; B Ryffel
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

Review 3.  Pathophysiology of fatal falciparum malaria in African children.

Authors:  C R Newton; T E Taylor; R O Whitten
Journal:  Am J Trop Med Hyg       Date:  1998-05       Impact factor: 2.345

4.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor.

Authors:  G E Grau; H Heremans; P F Piguet; P Pointaire; P H Lambert; A Billiau; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response.

Authors:  W Rudin; H P Eugster; G Bordmann; J Bonato; M Müller; M Yamage; B Ryffel
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Profiles of cytokine production in relation with susceptibility to cerebral malaria.

Authors:  S de Kossodo; G E Grau
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

7.  Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice.

Authors:  J H Curfs; P H van der Meide; A Billiau; J H Meuwissen; W M Eling
Journal:  Exp Parasitol       Date:  1993-09       Impact factor: 2.011

8.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

9.  Intraleucocytic malaria pigment and prognosis in severe malaria.

Authors:  P H Nguyen; N Day; T D Pram; D J Ferguson; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Mar-Apr       Impact factor: 2.184

10.  Low dosages of interleukin 1 protect mice against lethal cerebral malaria.

Authors:  J H Curfs; J W van der Meer; R W Sauerwein; W M Eling
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Toll-like receptors in innate immunity and infectious diseases.

Authors:  Min-Hao Wu; Ping Zhang; Xi Huang
Journal:  Front Med China       Date:  2010-12-02

2.  Do you see what I see: Recognition of protozoan parasites by Toll-like receptors.

Authors:  Debopam Ghosh; Jason S Stumhofer
Journal:  Curr Immunol Rev       Date:  2013-08

3.  Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.

Authors:  Bernardo S Franklin; Sally T Ishizaka; Marc Lamphier; Fabian Gusovsky; Hans Hansen; Jeffrey Rose; Wanjun Zheng; Marco Antônio Ataíde; Rosane B de Oliveira; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-08       Impact factor: 11.205

Review 4.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

5.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

6.  Role of polymorphisms of toll-like receptor (TLR) 4, TLR9, toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children.

Authors:  Susanna Esposito; Claudio Giuseppe Molteni; Alberto Zampiero; Elena Baggi; Anna Lavizzari; Margherita Semino; Cristina Daleno; Michela Groppo; Alessia Scala; Leonardo Terranova; Monica Miozzo; Claudio Pelucchi; Nicola Principi
Journal:  Malar J       Date:  2012-06-12       Impact factor: 2.979

7.  Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study.

Authors:  Ahmeddin H Omar; Michio Yasunami; Akiko Yamazaki; Hiroki Shibata; Michael F Ofori; Bartholomew D Akanmori; Mohammed Nasir Shuaibu; Mihoko Kikuchi; Kenji Hirayama
Journal:  Malar J       Date:  2012-05-17       Impact factor: 2.979

8.  Toll-like receptor 9 and 4 gene polymorphisms in susceptibility and severity of malaria: a meta-analysis of genetic association studies.

Authors:  Cho Naing; Siew Tung Wong; Htar Htar Aung
Journal:  Malar J       Date:  2021-07-03       Impact factor: 2.979

9.  Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors.

Authors:  Marieke S Sanders; Gijs T J van Well; Sander Ouburg; Servaas A Morré; A Marceline van Furth
Journal:  BMC Infect Dis       Date:  2012-05-11       Impact factor: 3.090

10.  Toll-like receptors and human disease: lessons from single nucleotide polymorphisms.

Authors:  Yi-Tzu Lin; Amanda Verma; Conrad P Hodgkinson
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.